SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-20-006411
Filing Date
2020-09-11
Accepted
2020-09-11 08:30:17
Documents
12
Period of Report
2020-09-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_091120.htm   iXBRL 8-K 30016
  Complete submission text file 0001171843-20-006411.txt   207778

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE crvs-20200910.xsd EX-101.SCH 3201
3 XBRL LABEL FILE crvs-20200910_lab.xml EX-101.LAB 34591
4 XBRL PRESENTATION FILE crvs-20200910_pre.xml EX-101.PRE 22720
5 EXTRACTED XBRL INSTANCE DOCUMENT f8k_091120_htm.xml XML 3725
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37719 | Film No.: 201170000
SIC: 2834 Pharmaceutical Preparations